Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00933114 · ClinicalTrials.gov registry record
Functional Imaging of Tumor and Normal Tissue
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 21
- Enrollment target
NCT00933114 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 21 participants.
The verdict
NCT00933114 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Dynamic contrast-enhanced (DCE) - magnetic resonance imaging (MRI), diffusion-weighted (DW)-MRI, and fludeoxyglucose - positron emission tomography - computed tomography (FDG-PET-CT) are three modalities that generate non-invasive, functional images of tumors and normal tissues based on physiologic properties including perfusion, vascular permeability and glucose metabolism. Demonstrating that these parameters are associated with clinical outcome, either efficacy or toxicity, could enhance the ability to select patients for different treatment strategies and improve the therapeutic ratio.
Interventions
- PROCEDURE MRI and PET imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00933114
The ClinicalTrials.gov registry entry for NCT00933114 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI and PET imaging is the first listed.
NCT00933114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00933114 about?
NCT00933114 is a clinical study titled "Functional Imaging of Tumor and Normal Tissue". Dynamic contrast-enhanced (DCE) - magnetic resonance imaging (MRI), diffusion-weighted (DW)-MRI, and fludeoxyglucose - positron emission tomography - computed tomography (FDG-PET-CT) are three modalities that generate non-invasive, functional images of tumors and normal tissues based on physiologic ...
What is the current status of trial NCT00933114?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2009-10. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00933114?
The interventions under investigation include: MRI and PET imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00933114?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.